InVivo Therapeutics
(NASDAQ) NVIV
InVivo Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$9.33M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
NVIV News
NVIV: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout InVivo Therapeutics
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
6
CEO
Richard Toselli, MD, MBA
Website
www.invivotherapeutics.comHeadquarters
Cambridge, MA 02139, US
NVIV Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-60%
Return on Capital
-65%
Return on Assets
-54%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$445.00K
Operating Income
$10.65M
EBITDA
$9.89M
Operating Cash Flow
$10.48M
Capital Expenditure
$160.00K
Free Cash Flow
$10.64M
Cash & ST Invst.
$16.35M
Total Debt
$949.00K
InVivo Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$72.00K
+34.5%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
6
N/A
Net Income
$2.70M
+2.1%
EBITDA
$2.70M
-3.7%
Quarterly Fundamentals
Net Cash
$8.58M
-10.2%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$0.00
-100.0%
Return on Assets
-54.08%
N/A
Return on Invested Capital
-65.12%
N/A
Free Cash Flow
$2.28M
+6.1%
Operating Cash Flow
$2.28M
+3.7%